Updated on December 23, 2025 to include the FDA approval of the Wegovy®pill by Novo Nordisk. With FDA-approval of the Wegovy® pill by Novo Nordisk in December 2025, the first oral versions ofGLP-1 weight loss medications are scheduled to reach the market in January 2026. Eli Lilly’s weight loss pill, Orforglipron, is still awaiting FDA-approval […]
Wegovy®, Saxenda®, and Qsymia® are FDA-Approved Prescription Weight Loss Medications Available to Weight Loss Patients in New Jersey Who Qualify With so many choices how do you know which medication is best for you? Here's some points to help you decide. Do I Qualify for Weight Loss Medications? First, determine if you meet the criteria […]


